ARÇAY ÖZTÜRK, A. Et Al. 2018. Clinical Role of FDG PET/CT in Differantiated Thyroid Cancer Patients with Elaveted Tumor Markers. Annual Congress of the European Association of Nuclear Medicine 2018 , (Germany).

ARÇAY ÖZTÜRK, A., YILMAZ, N., & AYDIN, F., (2018). Clinical Role of FDG PET/CT in Differantiated Thyroid Cancer Patients with Elaveted Tumor Markers . Annual Congress of the European Association of Nuclear Medicine 2018, Germany

ARÇAY ÖZTÜRK, AYÇA, NUSRET YILMAZ, And FUNDA AYDIN. "Clinical Role of FDG PET/CT in Differantiated Thyroid Cancer Patients with Elaveted Tumor Markers," Annual Congress of the European Association of Nuclear Medicine 2018, Germany, 2018

ARÇAY ÖZTÜRK, AYÇA A. Et Al. "Clinical Role of FDG PET/CT in Differantiated Thyroid Cancer Patients with Elaveted Tumor Markers." Annual Congress of the European Association of Nuclear Medicine 2018 , Germany, 2018

ARÇAY ÖZTÜRK, A. YILMAZ, N. And AYDIN, F. (2018) . "Clinical Role of FDG PET/CT in Differantiated Thyroid Cancer Patients with Elaveted Tumor Markers." Annual Congress of the European Association of Nuclear Medicine 2018 , Germany.

@conferencepaper{conferencepaper, author={AYÇA ARÇAY ÖZTÜRK Et Al. }, title={Clinical Role of FDG PET/CT in Differantiated Thyroid Cancer Patients with Elaveted Tumor Markers}, congress name={Annual Congress of the European Association of Nuclear Medicine 2018}, city={}, country={Germany}, year={2018}}